The metabolic effect of antipsychotic medicatio

Phase 4

• Conditions: Schizophrenia; Glucose intolerance; Mental Health - Schizophrenia; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12610000911099
• Lead Sponsor: niversity of Auckland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-10-26
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Male
• Target Recruitment: 20

Inclusion Criteria

BMI 20-25
healthy male volunteers

Exclusion Criteria

family or personal history of diabetes, schizophrenia.
current regular medications.
smoker

Study & Design

• Study Type: Interventional
• Study Design: Not specified